Filed: 8/11/2023ACC: 0000935836-23-000564
📋 What this filing means
STONEPINE CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $266.19M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$266.19M
Total AUM (reported)
43.78M
Total Shares
Allocation by class
COM$204.17M76.7%
COM NEW$31.37M11.8%
SPON ADR$27.76M10.4%
SHS$2.90M1.1%
Portfolio Concentration
Top 3$116.53M43.8%
4–10$116.68M43.8%
11–25$32.98M12.4%
Top 3 weight
43.8%
Top 10 weight
87.6%
Voting Authority Distribution
Total shares with voting rights: 43.78M
Sole
Full voting authority
43.78M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
QUIDELORTHO CORP
SOLEShares619.43K
TypeSH
Market value$51.33M
19.28%
Sole
619.43K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares4.51M
TypeSH
Market value$32.76M
12.31%
Sole
4.51M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares8.79M
TypeSH
Market value$32.45M
12.19%
Sole
8.79M
Shared
0.00
None
0.00
GALAPAGOS NV-SPON ADR
SOLEShares682.66K
TypeSH
Market value$27.76M
10.43%
Sole
682.66K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares1.12M
TypeSH
Market value$24.18M
9.08%
Sole
1.12M
Shared
0.00
None
0.00
MAXCYTE INC
SOLEShares3.97M
TypeSH
Market value$18.21M
6.84%
Sole
3.97M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares5.50M
TypeSH
Market value$14.41M
5.41%
Sole
5.50M
Shared
0.00
None
0.00
THIRD HARMONIC BIO INC
SOLEShares2.79M
TypeSH
Market value$13.44M
5.05%
Sole
2.79M
Shared
0.00
None
0.00
ATYR PHARMA INC
SOLEShares4.63M
TypeSH
Market value$9.99M
3.75%
Sole
4.63M
Shared
0.00
None
0.00
SCYNEXIS INC
SOLEShares2.95M
TypeSH
Market value$8.69M
3.27%
Sole
2.95M
Shared
0.00
None
0.00
XOMA CORP
SOLEShares349.40K
TypeSH
Market value$6.60M
2.48%
Sole
349.40K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares3.07M
TypeSH
Market value$6.08M
2.29%
Sole
3.07M
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares482.62K
TypeSH
Market value$4.89M
1.84%
Sole
482.62K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares448.51K
TypeSH
Market value$4.64M
1.74%
Sole
448.51K
Shared
0.00
None
0.00
EXAGEN INC
SOLEShares1.05M
TypeSH
Market value$3.04M
1.14%
Sole
1.05M
Shared
0.00
None
0.00
GAMIDA CELL LTD
SOLEShares1.50M
TypeSH
Market value$2.90M
1.09%
Sole
1.50M
Shared
0.00
None
0.00
ATEA PHARMACEUTICALS INC
SOLEShares752.09K
TypeSH
Market value$2.81M
1.06%
Sole
752.09K
Shared
0.00
None
0.00
CASTLE BIOSCIENCES INC
SOLEShares91.98K
TypeSH
Market value$1.26M
0.47%
Sole
91.98K
Shared
0.00
None
0.00
AYTU BIOPHARMA INC
SOLEShares472.37K
TypeSH
Market value$755.8K
0.28%
Sole
472.37K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
QUIDELORTHO CORPSOLE | COM | 619.43K | SH | $51.33M 19.28% | 619.43K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 4.51M | SH | $32.76M 12.31% | 4.51M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 8.79M | SH | $32.45M 12.19% | 8.79M | 0.00 | 0.00 |
GALAPAGOS NV-SPON ADRSOLE | SPON ADR | 682.66K | SH | $27.76M 10.43% | 682.66K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 1.12M | SH | $24.18M 9.08% | 1.12M | 0.00 | 0.00 |
MAXCYTE INCSOLE | COM | 3.97M | SH | $18.21M 6.84% | 3.97M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 5.50M | SH | $14.41M 5.41% | 5.50M | 0.00 | 0.00 |
THIRD HARMONIC BIO INCSOLE | COM | 2.79M | SH | $13.44M 5.05% | 2.79M | 0.00 | 0.00 |
ATYR PHARMA INCSOLE | COM NEW | 4.63M | SH | $9.99M 3.75% | 4.63M | 0.00 | 0.00 |
SCYNEXIS INCSOLE | COM NEW | 2.95M | SH | $8.69M 3.27% | 2.95M | 0.00 | 0.00 |
XOMA CORPSOLE | COM NEW | 349.40K | SH | $6.60M 2.48% | 349.40K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 3.07M | SH | $6.08M 2.29% | 3.07M | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 482.62K | SH | $4.89M 1.84% | 482.62K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 448.51K | SH | $4.64M 1.74% | 448.51K | 0.00 | 0.00 |
EXAGEN INCSOLE | COM | 1.05M | SH | $3.04M 1.14% | 1.05M | 0.00 | 0.00 |
GAMIDA CELL LTDSOLE | SHS | 1.50M | SH | $2.90M 1.09% | 1.50M | 0.00 | 0.00 |
ATEA PHARMACEUTICALS INCSOLE | COM | 752.09K | SH | $2.81M 1.06% | 752.09K | 0.00 | 0.00 |
CASTLE BIOSCIENCES INCSOLE | COM | 91.98K | SH | $1.26M 0.47% | 91.98K | 0.00 | 0.00 |
AYTU BIOPHARMA INCSOLE | COM | 472.37K | SH | $755.8K 0.28% | 472.37K | 0.00 | 0.00 |